Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating serious infections: focus on cefepime.

Annie Wong-Beringer1

  • 1School of Pharmacy, University of Southern California, Los Angeles, California 90089, USA.

Pharmacotherapy
|December 9, 2004
PubMed
Summary

Antibiotic resistance threatens effective treatment of serious infections. This review covers infection causes, resistance threats, and the impact of inadequate empiric therapy, focusing on cefepime for pneumonia and febrile neutropenia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent infections caused by ESBL-producing enterobacterales with or without subsequent development of distinct carbapenem-resistant phenotypes: differential driving factors and impact on outcome.

JAC-antimicrobial resistance·2026
Same author

Effect of antibiotics on Kupffer cell immunometabolism relative to intracellular killing of <i>S. aureus</i> using NAD(P)H fluorescence lifetime imaging.

mBio·2025
Same author

ESBL-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Exhibit Divergent Paths During In-Human Evolution Towards Carbapenem Resistance.

Microorganisms·2025
Same author

Perceptual and technical barriers in sharing and formatting metadata accompanying omics studies.

Cell genomics·2025
Same author

Carbapenem de-escalation as an antimicrobial stewardship strategy: a narrative review.

JAC-antimicrobial resistance·2025
Same author

Comparison of phenotypic and genetic traits of ESBL-producing UPEC strains causing recurrent or single episode UTI in postmenopausal women.

Annals of clinical microbiology and antimicrobials·2025

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Pharmacology

Background:

  • Antibiotic resistance in key pathogens diminishes the effectiveness of broad-spectrum antibiotics for treating severe infections.
  • Emerging resistance poses a significant global health threat, complicating empiric treatment strategies.
  • Inadequate empiric therapy negatively impacts patient outcomes and hospital environments.

Purpose of the Study:

  • To provide an overview of the etiology and emerging resistance patterns of serious infections.
  • To review the adverse effects of insufficient empiric treatment on patients and healthcare settings.
  • To discuss the use of cefepime in treating specific infections like hospital-acquired pneumonia and febrile neutropenia.

Main Methods:

  • Literature review on antibiotic resistance, infection etiology, and treatment outcomes.
  • Analysis of the impact of empiric antibiotic therapy on patient prognosis.
  • Case discussion of cefepime efficacy in pneumonia and febrile neutropenia.

Main Results:

  • Growing antibiotic resistance is a major challenge in managing serious infections.
  • Suboptimal empiric treatment leads to poorer patient outcomes and contributes to resistance spread.
  • Cefepime demonstrates clinical utility in treating specific serious infections.

Conclusions:

  • Addressing antibiotic resistance is crucial for preserving therapeutic options.
  • Optimizing empiric treatment strategies is essential for improving patient care and infection control.
  • Cefepime remains a valuable agent for specific indications in the context of evolving resistance patterns.

Related Experiment Videos